Pargyline

Pargyline

SCHEMBL4441967

C#CCN(C)Cc1ccccc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAOAMAOB

The experimentally established mechanism targets of Pargyline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAOB known ✓ P27338 3/20 0.75
MAOA known ✓ P21397 2/20 0.75
PYCR1 P32322 14/20 0.75
LMNA P02545 2/20 0.75
USP2 O75604 1/20 0.75
CYP3A4 P08684 1/20 0.75
TSHR P16473 1/20 0.75
ALDH1A1 P00352 1/20 0.73
BLM P54132 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pargyline SCHEMBL18036659 0.87 PYCR1 (1.00) PYCR1MAOBLMNAMAOAUSP2
Pargyline SCHEMBL2045 0.87 PYCR1 (1.00) PYCR1MAOBLMNAMAOAUSP2
Dibemethine SCHEMBL9416520 0.85 NPC1 (0.63) TSHRALDH1A1SMN1; SMN2NPC1RAB9A
Dibemethine SCHEMBL9416516 0.85 NPC1 (0.63) TSHRALDH1A1SMN1; SMN2NPC1RAB9A
Pargyline SCHEMBL7363311 0.85 PYCR1 (0.96) PYCR1MAOBLMNAMAOAUSP2
Pargyline SCHEMBL121111 0.85 LMNA (1.00) PYCR1MAOBLMNAMAOAUSP2
Pargyline SCHEMBL5981667 0.84 PYCR1 (0.75) PYCR1MAOBLMNAMAOAUSP2
SCHEMBL10033811 0.84 PYCR1 (0.60) PYCR1MAOBLMNAMAOAUSP2
Pargyline SCHEMBL2657939 0.80 PYCR1 (0.86) PYCR1MAOBLMNAMAOAUSP2
SCHEMBL10033801 0.78 PYCR1 (0.79) PYCR1MAOBLMNAMAOAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120899-A1 ANTIHYPERTENSIVE DRUG COMBINATION Gilead Colorado, Inc. (US) 2009-11-25 EP disclosed
WO-2008100803-A1 ANTIHYPERTENSIVE DRUG COMBINATION GILEAD COLORADO, INC. (US) 2008-08-21 WO disclosed